July 10, 2024
Researchers have created an eco-friendly, blood absorbent biomaterial that improves the performance of menstrual products by minimizing blood leakage and spilling, while also helping prevent infection.
July 9, 2024
Pasta without sauce. Unsalted crackers. Plain white rice. What is traditionally known to be the renal diet — a complicated diet with a wide range of restrictions, including limited protein, potassium, phosphorus and sodium — often lacks flavor and color, leaving individuals with chronic kidney disease (CKD) who have been prescribed the diet dissatisfied with their meal options. Some patients go as far as ignoring aspects of the diet altogether.
July 3, 2024
Purdue University, as a member of Heartland BioWorks, will share $51 million in federal funding to bolster workforce development and business startup efforts in the state’s burgeoning biotechnology ecosystem. Awarded by the U.S. Department of Commerce’s Economic Development Administration, the funding will catalyze Indiana’s biotechnology innovation and manufacturing efforts, which are a pillar of Purdue’s recently announced One Health Innovation District. One Health will also bolster the deep connections and research opportunities that will be offered through Purdue University in Indianapolis, which launched July 1 as the university’s urban campus.
July 1, 2024
Screening eligibility was determined using 2021 U.S. Preventive Services Task Force criteria, which recommend annual lung cancer screening in high-risk individuals.
Fewer than 1 in 5 eligible Americans up to date with lung cancer screenings
July 1, 2024
Despite widespread belief that sex hormones are important to women's brain health, little work has considered how these hormones in women relate to white matter hyperintensities (WMH), a major indicator of cerebral small vessel disease. We considered relations of estradiol (E2), estrone (E1), and follicle-stimulating hormone (FSH) to WMH in midlife women. Higher E2 and E1 were associated with lower whole-brain WMH volume (WMHV), and higher FSH with higher whole-brain WMHV. Associations of E1 and FSH, but not E2, to WMHV persisted with adjustment for cardiovascular disease risk factors. Findings underscore the importance of E2 and FSH to women's cerebrovascular health.
Reproductive hormones in relation to white matter hyperintensity volumes among midlife women
June 26, 2024
The injectable antiretroviral drug lenacapavir was safe and 100% effective as long-acting HIV pre-exposure prophylaxis (PrEP) among cisgender women in a Phase 3 clinical trial, according to top-line findings released by Gilead Sciences, Inc., the study sponsor. Lenacapavir is administered every six months, making it the most durable HIV prevention method to have shown efficacy in this population. NIAID applauds the study sponsor, investigators, study staff, and—most importantly—the participants in South Africa and Uganda, for contributing to this scientific advance for cisgender women, a population for whom biomedical HIV prevention evidence has been limited to date. We look forward to the release of additional data from this pivotal study, as well as the outcomes of companion studies of lenacapavir in other populations, to inform regulatory decisions on this novel PrEP method.
June 24, 2024
If you’re a cancer researcher looking to build artificial intelligence (AI) models that predict cancer treatment response, there’s a new resource available! A team led by Dr. Eytan Ruppin and Dr. Alejandro Schäffer developed an AI-driven tool called PERsonalized single-Cell Expression-based Planning for Treatments in ONcology (PERCEPTION).
Predicting Cancer Treatment Responses with AI Tool PERCEPTION
June 21, 2024
Oncologists and researchers increasingly focus on how to predict, treat and monitor for cardiovascular problems that develop before and after treatment.
June 20, 2024
The NIH Office of Research on Women’s Health (ORWH) and Office of AIDS Research (OAR), in partnership with multiple NIH institutes and centers (ICs) including NIAID, have issued a Notice of Special Interest (NOSI): Research Opportunities Centering the Health of Women Across the HIV Research Continuum to invite HIV-related research that explicitly and intersectionally center the health needs of cisgender women and girls, and gender-diverse people.
New Initiative Shines a Spotlight on Women’s Health in HIV Research Continuum
June 18, 2024
Are you looking for a better way to biopsy for cancer, especially in deep tissue areas such as the lung and brain that aren’t readily accessible? In a study funded by NCI, researchers used machine learning to find a potential new biomarker that may someday help.
